Financhill
Back

ProShares Ultra Nasdaq Biotechnology Vs. Qualys Industry Stock Comparison

Sell
50

BIB
ProShares Ultra Nasdaq Biotechnology

Last Price:
65.71
Seasonality Move:
14.04%
Buy
59

QLYS
Qualys

Last Price:
157.01
Seasonality Move:
7.29%
Sell
50
ProShares Ultra Nasdaq Biotechnology (BIB) is a Sell

Is ProShares Ultra Nasdaq Biotechnology a Buy, Sell or Hold?

  • The current ProShares Ultra Nasdaq Biotechnology [BIB] share price is $64.31. The Score for BIB is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • BIB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
59
Qualys (QLYS) is a Buy

Is Qualys a Buy, Sell or Hold?

  • The current Qualys [QLYS] share price is $159.33. The Score for QLYS is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
  • QLYS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

BIB Stock Price Chart

What is ProShares Ultra Nasdaq Biotechnology's stock price today?

  • The ProShares Ultra Nasdaq Biotechnology share price today is $64.31
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BIB is experiencing slight buying pressure.

QLYS Stock Price Chart

What is Qualys's stock price today?

  • The Qualys share price today is $159.33
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and QLYS is experiencing slight buying pressure.

BIB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.31 Sell
Relative Strength Index (14 RSI): 55.47 Buy
Chaikin Money Flow: 680 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (61.29 - 64.17) Buy
Bollinger Bands (100): (60.67 - 66.55) Buy

QLYS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.43 Buy
Relative Strength Index (14 RSI): 81.69 Buy
Chaikin Money Flow: 702817 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (117.79 - 132.57) Buy
Bollinger Bands (100): (121.53 - 140.17) Buy

BIB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 62.39 Buy
20-day SMA: 63.05 Buy
50-day SMA: 63.92 Buy
200-day SMA: 59.83 Buy
8-day EMA: 62.7 Buy
20-day EMA: 62.84 Buy
50-day EMA: 63.29 Buy
200-day EMA: 60.29 Buy

QLYS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 127.35 Buy
20-day SMA: 125.33 Buy
50-day SMA: 124.95 Buy
200-day SMA: 147.03 Buy
8-day EMA: 131.44 Buy
20-day EMA: 126.91 Buy
50-day EMA: 126.9 Buy
200-day EMA: 140.31 Buy

ProShares Ultra Nasdaq Biotechnology Earnings Growth & BIB Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Qualys Earnings Growth & QLYS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.78 per share, and an increase next year of $0.14 per share.

ProShares Ultra Nasdaq Biotechnology Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Qualys Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):